One by One UHC Conference 2018
GLOBAL BARRIERS, synergies and opportunities for achieving universal health coverage
SEPTEMBER 24, 2018 • New York, NY
How can experts from 4 major disease areas work together for UHC?
The Access Challenge held a high-level UHC conference as part of the launch of its new One by One: Target 2030 Campaign to begin a global dialogue on barriers, synergies, and opportunities along the pathway to UHC.
We convened the foremost leaders in of four disease groups together to discuss their disease-specific insights into the barriers to achieving UHC on the timeline articulated by Director-General Dr. Tedros Adhanom Ghebreyesus. The conference culminated in a high-level dinner and awards ceremony to celebrate three extraordinary UHC leaders.
The Access Challenge launched its UHC Conference 2018 report in Cape Verde at the Second WHO Afro Health Forum, in March, 2019.
H.E. President Jakaya Mrisho Kikwete
Former President of the United Republic of Tanzania (2005-2015)
Dr. Tedros Adhanom Ghebreyesus
World Health Organization
Ms. Kate Campana
Founder and Chief Executive Officer
The Access Challenge
Dr. Chris Elias
President, Global Development Division
Bill & Melinda Gates Foundation
Mr. Achim Steiner
United Nations Development Programme
Dr. Carmen Villar
Vice President of Social Business Innovation
Merck & Co.
H.E. Dr. Joyce Banda
Former President of Malawi
Mr. Pape Amadou Gaye
President and CEO, Intrahealth
Dr. Mariam Claeson
Director, Global Financing Facility
Dr. Edna Adan Ismail
Director and Founder, Edna Adan Maternity Hospital, Former Foreign Minister of Somaliland
Mrs. Bineta Diop
AU Special Envoy on Women, Peace and Security
Hon. Dr. Patrick Ndimubanzi
Honorable Minister of State in Charge of Public Health and Primary Health Care, Ministry of Health Rwanda
MATERNAL HEALTH OBJECTIVES
Build a shared understanding of what constitutes accessible, quality maternal health care in different contexts.
Explore the integral link between technology and training in the context of health system strengthening.
Identify strategies for the effective use of financial resources at global and national levels.
Shape policy objectives that will contribute to the achievement of UHC by 2030.
Dr. Mary-Ann Etiebet
Executive Director, Merck for Mothers
Following the conference, panelists met again to collaborate on the following set of guiding principles for women's health in order to drive its success within broader UHC action:
Keep Maternal Health Front and Center of the UHC Conversation, Devex, 11 Jan. 2019
Dr. Henry Mwanyika
Digital Health Regional Director for Africa, PATH
Mr. Kevin Watkins
CEO, Save the Children, UK
Dr. Stefan Swartling Peterson
Chief of Health, UNICEF
Dr. Katharina Lichtner
Managing Director, Family Larsson-Rosenquist Foundation
Dr. Kesete Admasu
CEO, RBM Partnership to
Identify the role that siloed, disease specific funding flows have on the development of effective PHC systems.
Identify how to leverage external disease specific funding flows to improve PHC systems.
Discuss the importance of government investment in PHC systems.
Understand the impact of disease specific advocacy vs. advocacy for domestic investment in health.
Identify how to extend the PHC systems through the use of community-based health workers and through the use of broad-based maternal health education.
Determine how to address critical funding gaps for PHC systems and for critical diagnostic and treatment tools like amoxicillin and oxygen.
H.E. Mrs. Toyin Saraki
Founder/President, The Wellbeing Foundation Africa and Global Goodwill Ambassador, ICM
Ms. Irene Koek
Senior Deputy Administrator for the Bureau for Global Health, USAID
Dr. Matshidiso Rebecca Moeti
Regional Director, WHO Regional Office for Africa
Dr. Agnes Binagwaho
Vice Chancellor, University of Global Health Equity, Former Minister of Health Rwanda
Dr. Sylvain Yuma
Secretary General for Health, Ministry of Health Democratic Republic of Congo
Dr. Luc Kuykens
Senior Vice President Global Health Programs, Sanofi
Consider the leading barriers to progress on achieving global NTD elimination targets by 2030.
Discuss the catalytic effect of public private partnerships/alliances in making the elimination of NTDs a reality.
Highlight the need for national leadership to build country capacity to eliminate NTDs.
Discuss how to achieve programmatic integration of NTDs into Primary Health Services so as to achieve synergies, save money, and thereby ensure universal access.
Identify key policies that could contribute to the achievement of UHC by 2030.
Dr. Maria Rebollo
ESPEN Team Leader, WHO Regional Office for Africa
Mr. David Barash
Executive Director, Global Health and Chief Medical Officer of
Dr. Asaf Bitton, MD, MPH
Director of Primary Health Care, Ariadne Labs
Ms. Helen-Marie Seibel
Director of Global Community Investment, AstraZeneca
Dr. Karlee Silver
Co-CEO, Grand Challenges Canada
Dr. Joseph Lubega
Director Global HOPE,
Texas Children’s Hospital, Bristol-Myers Squibb Foundation
Identify what is being done to improve diagnosis and treatment of NCDs.
Outline solutions to issues of access and discuss how to make a wider variety of prevention and treatment options more readily available in Africa.
Discuss private sector engagement.
Discuss what investments can be made to address NCDs.
Shape policy objectives that will contribute to the achievement of the UHC 2030 agenda.